Amplifon (OTCMKTS:AMFPF) vs. Alignment Healthcare (NASDAQ:ALHC) Financial Survey

Alignment Healthcare (NASDAQ:ALHCGet Free Report) and Amplifon (OTCMKTS:AMFPFGet Free Report) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

Insider and Institutional Ownership

86.2% of Alignment Healthcare shares are held by institutional investors. 5.2% of Alignment Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Alignment Healthcare and Amplifon”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Alignment Healthcare $3.95 billion 0.94 -$720,000.00 $0.09 199.22
Amplifon $2.61 billion 1.01 $157.31 million $0.76 15.68

Amplifon has lower revenue, but higher earnings than Alignment Healthcare. Amplifon is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Alignment Healthcare and Amplifon, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alignment Healthcare 0 3 6 2 2.91
Amplifon 0 2 2 0 2.50

Alignment Healthcare presently has a consensus price target of $24.60, suggesting a potential upside of 37.20%. Given Alignment Healthcare’s stronger consensus rating and higher possible upside, analysts clearly believe Alignment Healthcare is more favorable than Amplifon.

Profitability

This table compares Alignment Healthcare and Amplifon’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Alignment Healthcare 0.47% 11.50% 1.79%
Amplifon 4.74% 14.28% 3.89%

Risk & Volatility

Alignment Healthcare has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Amplifon has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500.

Summary

Alignment Healthcare beats Amplifon on 9 of the 15 factors compared between the two stocks.

About Alignment Healthcare

(Get Free Report)

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

About Amplifon

(Get Free Report)

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.